These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21188152)

  • 1. Eye disorders in patients with multiple sclerosis: natural history and management.
    Graves J; Balcer LJ
    Clin Ophthalmol; 2010 Dec; 4():1409-22. PubMed ID: 21188152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disorders of vision in multiple sclerosis.
    Dhanapalaratnam R; Markoulli M; Krishnan AV
    Clin Exp Optom; 2022 Jan; 105(1):3-12. PubMed ID: 34348598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular manifestations of multiple sclerosis.
    Chen L; Gordon LK
    Curr Opin Ophthalmol; 2005 Oct; 16(5):315-20. PubMed ID: 16175046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute optic neuritis and vision complaints in multiple sclerosis.
    Torres-Torres R; Sanchez-Dalmau BF
    Curr Treat Options Neurol; 2015 Jan; 17(1):328. PubMed ID: 25399875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis.
    Grecescu M
    J Med Life; 2014; 7(4):538-41. PubMed ID: 25713617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuro-ophthalmology and multiple sclerosis.
    Maxner CE
    Am Orthopt J; 2006; 56():72-85. PubMed ID: 21149134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome.
    Eyre M; Hameed A; Wright S; Brownlee W; Ciccarelli O; Bowman R; Lim M; Wassmer E; Thompson D; Hemingway C; Hacohen Y
    Dev Med Child Neurol; 2018 Dec; 60(12):1244-1250. PubMed ID: 29637998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic neuritis and the neuro-ophthalmology of multiple sclerosis.
    Kaur P; Bennett JL
    Int Rev Neurobiol; 2007; 79():633-63. PubMed ID: 17531862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography in the diagnosis and management of optic neuritis and multiple sclerosis.
    Costello FE; Klistorner A; Kardon R
    Ophthalmic Surg Lasers Imaging; 2011 Jul; 42 Suppl():S28-40. PubMed ID: 21790109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optic neuritis in multiple sclerosis: diagnosis and prognosis data].
    Beddiaf A; de Sèze J
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S145-7. PubMed ID: 19361679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Color vision testing versus pattern visual evoked potentials and optical coherence tomography parameters in subclinical optic nerve involvement in multiple sclerosis.
    Yuksel B; Dogan B; Koctekin B; Atis N; Erdal A; Kurtulus F; Erol MK; Gomceli YB
    J Clin Neurosci; 2019 Mar; 61():48-53. PubMed ID: 30455132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of spectral domain optical coherence tomography and visual evoked potentials to identify unilateral optic neuritis.
    Behbehani R; Ali A; Al-Omairah H; Rousseff RT
    Mult Scler Relat Disord; 2020 Jun; 41():101988. PubMed ID: 32092503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis and the ophthalmologist.
    Mowry EM; Balcer LJ; Galetta SL
    Compr Ophthalmol Update; 2007; 8(1):39-49. PubMed ID: 17394758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of optical coherence tomography in the diagnosis of afferent visual pathway problems: A neuroophthalmic perspective.
    Costello F; Chen JJ
    Handb Clin Neurol; 2021; 178():97-113. PubMed ID: 33832689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.
    Manogaran P; Vavasour IM; Lange AP; Zhao Y; McMullen K; Rauscher A; Carruthers R; Li DKB; Traboulsee AL; Kolind SH
    Neuroimage Clin; 2016; 11():743-750. PubMed ID: 27330974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multiple facets of multiple sclerosis.
    Jenkins PF
    Am Orthopt J; 2007; 57():69-78. PubMed ID: 21149159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vision Disturbances in Multiple Sclerosis.
    Costello F
    Semin Neurol; 2016 Apr; 36(2):185-95. PubMed ID: 27116725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography.
    Khanifar AA; Parlitsis GJ; Ehrlich JR; Aaker GD; D'Amico DJ; Gauthier SA; Kiss S
    Clin Ophthalmol; 2010 Sep; 4():1007-13. PubMed ID: 20922034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efferent manifestations of multiple sclerosis.
    Subei AM; Eggenberger E
    Curr Opin Ophthalmol; 2012 Nov; 23(6):506-9. PubMed ID: 23042149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.